$ Value
$0
Shares
5,125
Price
$0
Filed
Mar 3
Insider
Name
Moshkevich Solomon
Title
PRESIDENT, CLINICALDIAGNOSTICS
CIK
0002010019
Roles
Transaction Details
Transaction Date
2026-03-02
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over four years. 25% of the RSUs vest on March 1, 2027 and the remaining RSUs vest in 12 equal quarterly installments thereafter. | Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. | The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.42 to $199.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.6750 to $200.5100 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.72 to $201.16 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The option shares are fully exercisable.
Filing Info
Moshkevich Solomon's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | NTRA | ▼ | $211K |
| 2026-04-01 | NTRA | ▼ | $202K |
| 2026-04-01 | NTRA | ▼ | $194K |
| 2026-03-10 | NTRA | ▼ | $187K |
| 2026-03-09 | NTRA | A | — |
| 2026-03-02 | NTRA | M | $49K |
| 2026-03-02 | NTRA | ▼ | $185K |
| 2026-03-02 | NTRA | ▼ | $319K |
| 2026-03-02 | NTRA | ▼ | $95K |
| 2026-03-02 | NTRA | M | $0 |
Other Insiders at NTRA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| BOTHA ROELOF | — | — | 2026-01-30 |
| ROSENMAN HERM | — | — | 2026-01-30 |
| Williams Brinkley Ruth | — | — | 2026-01-30 |
|
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
|
— | $38.3M | 2026-04-06 |
| Sheena Jonathan | — | $2.4M | 2026-04-17 |
| Baynes Roy D. | — | — | 2026-01-30 |
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
|
— | $2.9M | 2026-03-10 |
| Marcus Gail Boxer | — | — | 2026-01-30 |
|
Chapman Steven Leonard
CEO AND PRESIDENT
|
— | $24.1M | 2026-03-10 |
| Bertagnolli Monica | — | — | 2026-01-30 |
| Chapman Rowan E | — | $23K | 2026-03-13 |
|
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
|
— | $4.5M | 2026-04-01 |
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
|
— | $3.0M | 2026-04-01 |
|
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
|
— | $1.4M | 2026-03-10 |